ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,547.89
0.78%
US Tech 100
19,259.60
1.32%
Dow Jones
40,390.64
0.26%
Brent Oil
81.57
-0.86%
Bitcoin
66,781.54
-2.02%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Gpc Biotech AG ADS (MM) (GPCB)

  7. Gpc Biotech AG ADS (MM) (GPCB) News

GPCB

Gpc Biotech AG ADS (MM) (GPCB)

Gpc Biotech AG ADS (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GPCB
DateTimeSourceHeadlineSymbolCompany
04/21/200910:12AMBusiness WireNew Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACRNASDAQ:GPCBGpc Biotech AG ADS (MM)
03/25/20092:40AMBusiness WireGPC Biotech Reports Financial Results for Fiscal Year 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
02/23/20092:17PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
02/17/20098:31PMBusiness WireGPC Biotech and Agennix Announce Proposed MergerNASDAQ:GPCBGpc Biotech AG ADS (MM)
12/09/20084:10AMBusiness WireGPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with ...NASDAQ:GPCBGpc Biotech AG ADS (MM)
11/19/200810:53AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
11/18/200811:53AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
11/14/20081:57PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
11/13/20081:40AMBusiness WireGPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
11/06/20089:42AMBusiness WireGPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
08/25/20083:13PMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
08/14/200812:12PMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
08/13/200812:51PMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
08/13/20089:57AMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
08/06/20086:01PMBusiness WireGPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for SatraplatinNASDAQ:GPCBGpc Biotech AG ADS (MM)
07/25/20084:15PMBusiness WireGPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be WithdrawnNASDAQ:GPCBGpc Biotech AG ADS (MM)
06/12/20084:05AMBusiness WireGPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to TaxanesNASDAQ:GPCBGpc Biotech AG ADS (MM)
06/05/20082:49AMBusiness WireGPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
06/02/20083:06AMBusiness WireData from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial ChemotheNASDAQ:GPCBGpc Biotech AG ADS (MM)
06/02/20083:05AMBusiness WireNew Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
05/28/20083:07AMBusiness WireGPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
05/15/20082:36AMBusiness WireGPC Biotech Reports Financial Results for First Quarter 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
04/01/20085:14PMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
04/01/20083:07PMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
02/25/20084:04PMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
01/31/20081:42PMEdgar (US Regulatory)Gpc Biotech Ag - Amended Statement of Ownership (SC 13G/A)NASDAQ:GPCBGpc Biotech AG ADS (MM)
12/05/200710:37AMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
11/06/20078:01AMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
10/31/20078:05AMEdgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
10/30/200711:35PMPR Newswire (US)GPC Biotech Today Announced Results of Survival Analysis from the SPARC TrialNASDAQ:GPCB
 Showing the most relevant articles for your search:NASDAQ:GPCB

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
INCT
Incapta (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
RONN
Ronn Motor (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
CNNA
Cann American (CE)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
COOP
Mr Cooper
USOTC
AABB
Asia Broadband (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
AVXL
Anavex Life Sciences
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved